Fundraising Fox

KeChow Pharma

3 known investors

Kechow Pharma is a clinical-stage drug discovery company developing original novel small-molecule therapies for oncology and free-radical-related diseases. Its pipeline consists of new chemical entities aimed at unmet clinical needs in China and globally, targeting highly selective targeted drugs.

BiotechHealthtech

Investors · 3

Decheng CapitalMenlo Park
Qiming Venture PartnersBeijing · $5M – $134M
Lilly Asia VenturesreportedHong Kong

In the news

China's KeChow Pharma gets $45m Series C | AVCJavcj.com · Dec 2019KeChow Pharma Completes USD 45 Million Series C, Eyes an IPO Debut | EqualOceanequalocean.com · Dec 2019Decheng Capital Leads $45M Series C Round In Chinese Biopharmaceutical Firm KeChow Pharma – China Money Networkchinamoneynetwork.com · Dec 2019

Frequently asked questions

What does KeChow Pharma do?
Kechow Pharma is a clinical-stage drug discovery company developing original novel small-molecule therapies for oncology and free-radical-related diseases. Its pipeline consists of new chemical entities aimed at unmet clinical needs in China and globally, targeting highly selective targeted drugs.
Who are KeChow Pharma's investors?
KeChow Pharma's investors include Decheng Capital, Qiming Venture Partners, Lilly Asia Ventures.